Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

(2018) John E Edwards et al.   CLINICAL INFECTIOUS DISEASES

Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis

(2017) Junko Yano et al.   mBio

Pathogenesis ofCandida albicansbiofilm

(2016) Christina Tsui et al.   Pathogens and Disease

A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance

(2015) Christopher G Pierce et al.   npj Biofilms and Microbiomes

A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing

(2014) Christopher G Pierce et al.   Nature Protocols

Candida Vaginitis: When Opportunism Knocks, the Host Responds

(2014) Brian M. Peters et al.   PLoS Pathogens

NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response

(2013) Ashraf S. Ibrahim et al.   VACCINE

Interactions ofCandida albicanswith host epithelial surfaces

(2013) David W. Williams et al.   Journal of Oral Microbiology

Self-Adjuvanting Glycopeptide Conjugate Vaccine against Disseminated Candidiasis

(2012) Hong Xin et al.   PLoS One

Hidden Killers: Human Fungal Infections

(2012) G. D. Brown et al.   Science Translational Medicine

NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults

(2012) Clint S. Schmidt et al.   VACCINE

Vaccine and Monoclonal Antibody That Enhance Mouse Resistance to Candidiasis

(2011) Hong Xin et al.   Clinical and Vaccine Immunology

Active and Passive Immunization with rHyr1p-N Protects Mice against Hematogenously Disseminated Candidiasis

(2011) Guanpingsheng Luo et al.   PLoS One

Candida albicansHyr1p Confers Resistance to Neutrophil Killing and Is a Potential Vaccine Target

(2010) Guanpingsheng Luo et al.   JOURNAL OF INFECTIOUS DISEASES

Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle

(2010) Priya Uppuluri et al.   PLoS Pathogens

Improved Survival of Mice Deficient in Secretory Immunoglobulin M following Systemic Infection with Cryptococcus neoformans

(2009) K. S. Subramaniam et al.   INFECTION AND IMMUNITY

Considerable Differences in Vaccine Immunogenicities and Efficacies Related to the Diluent Used for Aluminum Hydroxide Adjuvant

(2008) L. Lin et al.   Clinical and Vaccine Immunology

Antibody Titer Threshold Predicts Anti‐Candidal Vaccine Efficacy Even though the Mechanism of Protection Is Induction of Cell‐Mediated Immunity

(2008) Brad Spellberg et al.   JOURNAL OF INFECTIOUS DISEASES